Obinutuzumab in kidney transplantation: Past, present, and future

Table 4 Cost of main B-cell, T-cell, and complement-targeted therapies in Italy

Active substance	Dosage form	Trade name	Manufacturer brand	Price per unit (€)
Rituximab	500 mg, 50 mL	Mabthera	Roche	2067
Ofatumumab	20 mg, 0.4 mL	Kesimpta	Novartis	2035
Ocrelizumab	300 mg, 10 mL	Ocrevus	Roche	9309
Ublituximab	150 mg, 6 mL	Briumvi	Neuraxpharm	5067
Obinutuzumab	1000 mg, 40 mL	Gazyvaro	Roche	4668
Daratumumab	1800 mg, 15 mL	Darzalex	Janssen-Cilag	8418
Bortezomib	3.5 mg	Bortezomib BV	Sandoz	1277
Alemtuzumab	12 mg, 1 mL	Lemtrada	Sanofi	13126
Thymoglobulin	50 mg, 10 mL	Thymoglobuline	Sanofi	239
Basiliximab	20 mg, 5 mL	Simulect	Novartis	1515
Belimumab	400 mg	Benlysta	GlaxoSmithKline	726
Eculizumab	300 mg, 30 mL	Soliris	Alexion	6852
Ravulizumab	100 mg, 11 mL	Ultomiris	Alexion	27407
Imlifidase	11 mg	Idefirix	Hansa Biopharma	245084
Intravenous human polyclonal immunoglobulin	10 g, 200 mL	Ig vena	Kedrion	1073
Fresh-frozen plasma	200 mL	Octaplas	Octapharma	75